Eris Lifesciences Limited (NSE:ERIS)

Eris Lifesciences Revenue

Eris Lifesciences had revenue of 7.72B INR in the quarter ending June 30, 2025, with 7.82% growth. This brings the company's revenue in the last twelve months to 29.35B, up 30.64% year-over-year. In the fiscal year ending March 31, 2025, Eris Lifesciences had annual revenue of 28.79B with 44.59% growth.

• Revenue (ttm): 29.35B
• Revenue Growth: +30.64%
• P/S Ratio: 7.82
• Revenue / Employee: 8.75M
• Employees: 3,354
• Market Cap: 229.44B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	28.79B	8.88B	44.59%
Mar 31, 2024	19.91B	3.29B	19.83%
Mar 31, 2023	16.62B	3.36B	25.31%
Mar 31, 2022	13.26B	1.34B	11.20%
Mar 31, 2021	11.93B	1.34B	12.71%